Bio-Rad Laboratories, Inc.

Case

[2019] APO 26

7 June 2019


Details
AGLC Case Decision Date
Bio-Rad Laboratories, Inc. [2019] APO 26 [2019] APO 26 7 June 2019

CaseChat Overview and Summary

The matter before the court involved Bio-Rad Laboratories, Inc., which was contesting an examiner's objection that the invention defined by the claims of its application was not in respect of a manner of manufacture. This objection was maintained in an examination report issued by the examiner. The applicant had previously amended and subsequently had the parent application granted, following a similar objection. The current application, which involved identical claims, faced the same objection. The applicant requested a hearing and filed written submissions along with proposed amendments to the specification and claims. The court was tasked with determining whether the claims in question defined a manner of manufacture and whether the proposed amendments were acceptable.

The primary legal issue before the court was whether the claims of the application defined a manner of manufacture as required by the Patents Act 1990. The court also had to consider whether the proposed amendments to the specification and claims resolved the objection and were compliant with the statutory requirements. The court was required to assess the sufficiency of the proposed amendments in light of the previous decision regarding the parent application and the principles established by the relevant case law.

The court carefully reviewed the claims and the proposed amendments, considering the background and technical details provided in the specification. The court noted that the claims were identical to those of the parent application, which had been accepted after amendments. The court found that the proposed amendments were sufficient to address the objection by clarifying that the invention was indeed a manner of manufacture. The court also found that the amendments aligned with the statutory requirements and existing case law. The court concluded that the claims, as amended, defined a manner of manufacture and that the application was patentable.

The court ordered that the application be accepted in its amended form and directed the Registrar to grant the patent to Bio-Rad Laboratories, Inc. The decision was made on the basis that the amended claims were in compliance with the statutory requirements and adequately defined a manner of manufacture. The court's decision was based on a thorough analysis of the claims, the specification, and the relevant legal principles, leading to a clear outcome in favor of the applicant.
Details

Areas of Law

  • Intellectual Property Law

Legal Concepts

  • Patent Law

  • Claims Construction

  • Amendment of Specification

Actions
Download as PDF Download as Word Document

Most Recent Citation
CareFusion 303, Inc. [2022] APO 40

Cases Citing This Decision

12

CareFusion 303, Inc. [2022] APO 40
Nuctech Company Limited [2021] APO 41
CareFusion 303, Inc. [2021] APO 12
Cases Cited

8

Statutory Material Cited

0